by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO
Biocon Ltd., a bio-pharmaceutical company, announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a Rs.1,125 Crore (approx. USD 150 million) fund raise from Goldman Sachs. As per the proposed terms, Goldman Sachs will be issued...
by Karan Vora | Jan 5, 2021 | Insights, Merger & Acquisitions, Private Equity & IPO
RBI announced a draft scheme for amalgamation of Lakshmi Vilas Bank (LVB) and DBS India Ltd (DBIL), wholly owned subsidiary of DBS Singapore in November. DBS will infuse Rs. 2500 Crore into DBIL as and when the scheme is approved. DBS is a major Singapore based bank....
by Karan Vora | Oct 13, 2020 | Articles, Capital Market Updates, Merger & Acquisitions, Private Equity & IPO
Read about fund raising by private banks through Qualified Institutional Placements (QIP), contraction in GDP and continued gains of stock markets in Capital Market updates published in September 2020 in Ahmedabad C.A. Journal. In Mergers & Acquisitions and...
by Karan Vora | Aug 29, 2020 | Debt Syndication, Financial Advisory, Insights, Private Equity & IPO
Economic Update: Monetary Policy committee of RBI met in 1st week of August and decided to keep the policy repo rate unchanged at 4% and continue with the accommodative stance of the monetary policy while ensuring that the inflation remains within target of 4% in...
by Karan Vora | Jan 22, 2020 | Insights
Indian Economic activity remained subdued in the month of November 2019. Gross domestic product (GDP) growth moderated to 4.5 per cent year-on-year (y-o-y) in Q2:2019-20, extending a sequential deceleration to the sixth consecutive quarter. Real GDP growth was weighed...
